1. Home
  2. OIS vs FULC Comparison

OIS vs FULC Comparison

Compare OIS & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil States International Inc.

OIS

Oil States International Inc.

HOLD

Current Price

$8.03

Market Cap

552.6M

Sector

Industrials

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.72

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OIS
FULC
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.6M
467.8M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
OIS
FULC
Price
$8.03
$3.72
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$14.00
$16.38
AVG Volume (30 Days)
589.3K
1.6M
Earning Date
05-05-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$1,088,133,000.00
N/A
Revenue This Year
$3.12
N/A
Revenue Next Year
$5.89
N/A
P/E Ratio
$425.00
N/A
Revenue Growth
62.26
N/A
52 Week Low
$4.75
$2.83
52 Week High
$14.50
$15.74

Technical Indicators

Market Signals
Indicator
OIS
FULC
Relative Strength Index (RSI) 41.24 44.49
Support Level $7.77 $3.41
Resistance Level $8.14 $4.02
Average True Range (ATR) 0.29 0.18
MACD 0.02 0.08
Stochastic Oscillator 6.70 76.54

Price Performance

Historical Comparison
OIS
FULC

About OIS Oil States International Inc.

Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: